[go: up one dir, main page]

ES551625A0 - Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos - Google Patents

Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos

Info

Publication number
ES551625A0
ES551625A0 ES551625A ES551625A ES551625A0 ES 551625 A0 ES551625 A0 ES 551625A0 ES 551625 A ES551625 A ES 551625A ES 551625 A ES551625 A ES 551625A ES 551625 A0 ES551625 A0 ES 551625A0
Authority
ES
Spain
Prior art keywords
gonamos
alquil
fenil
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551625A
Other languages
English (en)
Other versions
ES8701778A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19853504421 external-priority patent/DE3504421A1/de
Priority claimed from DE19853527517 external-priority patent/DE3527517A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES8701778A1 publication Critical patent/ES8701778A1/es
Publication of ES551625A0 publication Critical patent/ES551625A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES551625A 1985-02-07 1986-02-04 Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos Expired ES8701778A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853504421 DE3504421A1 (de) 1985-02-07 1985-02-07 Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19853527517 DE3527517A1 (de) 1985-07-29 1985-07-29 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
ES8701778A1 ES8701778A1 (es) 1986-12-16
ES551625A0 true ES551625A0 (es) 1986-12-16

Family

ID=25829248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551625A Expired ES8701778A1 (es) 1985-02-07 1986-02-04 Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos

Country Status (16)

Country Link
US (1) US5089635A (es)
EP (1) EP0190759B1 (es)
CN (1) CN1033753C (es)
AU (1) AU580843B2 (es)
CA (1) CA1310630C (es)
DE (1) DE3665307D1 (es)
DK (1) DK161709C (es)
ES (1) ES8701778A1 (es)
FI (1) FI85377C (es)
GR (1) GR860342B (es)
HU (1) HU194904B (es)
IE (1) IE58149B1 (es)
IL (1) IL77762A (es)
NO (1) NO171994C (es)
NZ (1) NZ214998A (es)
PT (1) PT81969B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
ATE69820T1 (de) * 1987-04-24 1991-12-15 Akzo Nv 11-arylestranderivate und 11-arylpregnanderivate.
AU625450B2 (en) * 1987-07-16 1992-07-09 Schering Aktiengesellschaft Berlin Und Bergkamen 11beta-phenyl-4,9,15-estratrienes, their manufacture, and pharmaceutical preparations containing them
DE3723788A1 (de) * 1987-07-16 1989-01-26 Schering Ag 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3878198T2 (de) * 1987-12-12 1993-06-24 Akzo Nv 11-arylsteroid-derivate.
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
FR2643638B1 (fr) * 1989-02-24 1991-06-14 Roussel Uclaf Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2665901B2 (fr) * 1989-02-24 1994-07-29 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine carbonee comportant une fonction amide, leur preparation, leur application comme medicaments.
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
GR1001164B (el) * 1989-07-07 1993-05-24 Endorecherche Inc Παραγωγα αρρενογονου ορμονης προς χρησιν εις την αναστολην δραστηριοτητος της στεροειδους ορμονης φυλου
AU5851690A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Method of treatment of androgen-related diseases
JP3202224B2 (ja) * 1989-08-04 2001-08-27 シエーリング アクチエンゲゼルシヤフト １１β―アリール―ゴナ―４，９―ジエン―３―オン、その製造方法及びそれを含有する調剤学的調製剤
DE4042007A1 (de) * 1990-12-22 1992-06-25 Schering Ag 6,7-modifizierte-11(beta)-aryl-4-estrene
DK0471612T3 (da) * 1990-08-14 1999-02-22 Hoechst Marion Roussel Inc Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.
HUT71514A (en) * 1992-05-21 1995-12-28 Endorecherche Inc Inhibitors of testosterone 5 alfa-reductase activity and pharmaceutical compositions containing the same
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
JP4260886B2 (ja) 1996-05-01 2009-04-30 アメリカ合衆国 新規の抗プロゲステロンとしての２１―置換プロゲステロン誘導体
IL122740A (en) * 1997-01-15 2003-09-17 Akzo Nobel Nv 16-hydroxy-11-(substituted phenyl)-estra-9,4-diene derivatives, their preparation and pharmaceutical compositions containing them
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
EP2576582B1 (en) 2010-05-26 2019-09-18 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
AU2016226451B2 (en) 2015-03-02 2019-12-19 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors
ES2906778T3 (es) 2015-03-30 2022-04-20 Corcept Therapeutics Inc Uso de antagonistas del receptor de glucocorticoides en combinación con glucocorticoides para tratar la insuficiencia suprarrenal
AU2016305092B2 (en) 2015-08-13 2022-01-27 Corcept Therapeutics, Inc. Method for differentially diagnosing ACTH-dependent Cushing's syndrome
EP3405101B1 (en) 2016-01-19 2020-12-23 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
SG11201908790PA (en) 2017-03-31 2019-10-30 Corcept Therapeutics Inc Glucocorticoid receptor modulators to treat cervical cancer
EP3641780B1 (en) 2017-06-20 2025-09-10 Corcept Therapeutics Incorporated Treatment of neuroepithelial tumors using selective glucocorticoid receptor modulators
JP2024500748A (ja) 2020-12-18 2024-01-10 インスティル バイオ （ユーケイ） リミテッド 腫瘍浸潤リンパ球の処理

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
DE3231827A1 (de) * 1982-08-24 1984-03-01 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-17(alpha)-alkinyl-17ss-hydroxy-4,9(10)- estradien-3-on-derivate, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
EP0190759B1 (de) 1989-08-30
CA1310630C (en) 1992-11-24
IE58149B1 (en) 1993-07-14
US5089635A (en) 1992-02-18
ES8701778A1 (es) 1986-12-16
DK161709C (da) 1992-01-13
DK56086D0 (da) 1986-02-05
NO171994C (no) 1993-05-26
FI860559L (fi) 1986-08-08
PT81969A (de) 1986-03-01
CN1033753C (zh) 1997-01-08
AU580843B2 (en) 1989-02-02
FI860559A0 (fi) 1986-02-07
EP0190759A3 (en) 1986-11-20
NO860425L (no) 1986-08-08
DE3665307D1 (en) 1989-10-05
CN86100994A (zh) 1986-10-08
FI85377C (fi) 1992-04-10
EP0190759A2 (de) 1986-08-13
NZ214998A (en) 1989-06-28
HUT40453A (en) 1986-12-28
AU5291386A (en) 1986-08-14
HU194904B (en) 1988-03-28
DK161709B (da) 1991-08-05
IE860334L (en) 1986-08-07
FI85377B (fi) 1991-12-31
PT81969B (pt) 1988-03-03
IL77762A (en) 1992-08-18
GR860342B (en) 1986-06-03
NO171994B (no) 1993-02-15
DK56086A (da) 1986-08-08

Similar Documents

Publication Publication Date Title
ES553138A0 (es) Procedimiento para la preparacion de 3-ariluracilos
ES551625A0 (es) Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos
ES547951A0 (es) Procedimiento para la preparacion de nuevas benzoilfenilu- reas
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
MX163569B (es) Procedimiento para la preparacion de benzoil-ureas
ES547924A0 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
ES551069A0 (es) Procedimiento para la preparacion de derivados de 13beta-alquil-milbenicina
MX162421A (es) Procedimiento para la preparacion de n-acilfenilalaninas
MX162552A (es) Procedimiento para la preparacion de benzoil-ureas
ES541906A0 (es) Procedimiento para la preparacion de glicidiloxidicetonas
ES553974A0 (es) Procedimiento para la preparacion de derivados de fenetanolamina
ES542071A0 (es) Procedimiento para la preparacion de ergolinas
IT8519652A0 (it) Procedimento per la preparazionedi alfa-omega-aloperfluorocarburi
MX162939B (es) Procedimiento mejorado para la preparacion de monoterbutiltolueno-diamina
AR243887A1 (es) Procedimiento para la preparacion de piridilcarbonil-tiazolonas cardiotonicas.
ES531159A0 (es) Procedimiento para la preparacion de aminociclotiadiazinas
ES553986A0 (es) Procedimiento para la obtencion de compuestos de heterociclil-penem
ES555278A0 (es) Procedimiento para la obtencion de derivados de diclorociclopropilalquilhidroxialquil-azol
ES555158A0 (es) Procedimiento para la preparacion de terpolimeros de etilenopropileno-dieno
ES557232A0 (es) Procedimiento para la preparacion de 3-ariluracilos
MX7420E (es) Procedimiento para la preparacion de carbamoil-lactama-n-substituida
ES549829A0 (es) Procedimiento para la preparacion de carbazatos
ES553066A0 (es) Procedimiento para la preparacion de colorantes monoazoicos
ES541017A0 (es) Procedimiento para la preparacion de propanolaminas
ES551623A0 (es) Procedimiento para la preparacion de acilureas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041025